Category list : Antiviral agents
Sort by: Newest first Oldest first A-Z Z-A
-
Lopinavir/ritonavir 'not effective' for patients hospitalised with COVID-19, third set of RECOVERY trial results show
An antiviral treatment commonly used to treat HIV has been found to have no beneficial effect in patients hospitalised with COVID-19, according to the third set of results to come out of the ‘Randomised Evaluation of COVID-19 Therapy’ trial.
-
No improvement in mortality rates for COVID-19 patients treated with remdesivir
There are “no statistically significant differences” for mortality and serious adverse events in COVID-19 patients treated with remdesivir, a rapid evidence review carried out by the National Institute for Health and Care Excellence has concluded.
-
No significant efficacy difference between courses of remdesivir in patients with severe COVID-19
There is no significant difference in efficacy between five-day and ten-day courses of the antiviral remdesivir for patients with severe COVID-19 not requiring ventilation, research published in The New England Journal of Medicine has shown.
-
First COVID-19 treatment to be made available for use in UK outside a clinical trial
Remdesivir will become the first COVID-19 treatment in the UK to be made available for use outside a clinical trial.
-
Remdesivir could be granted conditional marketing authorisation 'in the coming days', says EMA
The investigational antiviral medicine, remdesivir, may be granted a conditional marketing authorisation as a treatment for COVID-19 “in the coming days”, the head of the European Medicines Agency has said.
-
The hunt for an effective treatment for COVID-19
As researchers around the globe drop everything to find a treatment for COVID-19, we look at the likely frontrunners for managing this deadly disease.
-
Pharmacists able to dispense antivirals at earliest point in flu season for five years
The government has given pharmacists permission to dispense antiviral medicines at the expense of the NHS, in response to an increase in flu cases.
-
Hepatitis C: tackling the silent killer Subscription
About 200,000 people are living with hepatitis C in the UK, but it is estimated that around half of these remain undiagnosed. Identifying those at risk, offering tests and connecting those infected with treatment are crucial to tackling the disease.
-
HIV patients should have flu jab despite warnings, pharmacy group urges
HIV pharmacy specialists have warned that some HIV patients could be being mistakenly told that they should not take antiretrovirals at the same time as receiving the seasonal flu vaccination.
-
Naturally occurring peptides show antiviral potential against common cold Subscription
Cathelicidins could be a new therapeutic strategy for the management of human rhinovirus infection, researchers suggest.
